GLPwatch
Mounjaro vs Xultophy
Drug comparison
Last updated 2026-05-28 15:46 UTCMounjaro (tirzepatide) and Xultophy (liraglutide) are both injectable medications for type 2 diabetes, but they contain different active ingredients and are made by different companies. Mounjaro is made by Eli Lilly, while Xultophy is made by Novo Nordisk. Both are given as shots under the skin, but they work in slightly different ways to help control blood sugar.
AI summary of the sources below.
| Mounjaro | Xultophy | |
|---|---|---|
| Active ingredient | tirzepatide | liraglutide |
| Manufacturer | eli-lilly | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | 2026-04-22 | 2025-10-14 |